Clinicopathologic analysis of pancreatic adenocarcinoma in African Americans and Caucasians

Pancreas

Volumn 26, Issue 1, 2003, Pages 28-32

  Pernick, Nat L ^a,b   Sarkar, Fazlul H ^a   Philip, Philip A ^a   Arlauskas, Patricia ^a   Shields, Anthony F ^a   Vaitkevicius, Vainutis K ^a   Dugan, Michael C ^c   Adsay, N Volkan ^a,d  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Pathology Outlines com   (United States)

^c Santa Monica UCLA Medical Center   (United States)

^d HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

Chemotherapy; Ethnic group; K ras; Pancreatic adenocarcinoma; Race; Radiation therapy

Indexed keywords

DNA;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CAUCASIAN; ETHNIC GROUP; FEMALE; GENE MUTATION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NEGRO; ONCOGENE K RAS; PANCREAS ADENOCARCINOMA; PANCREAS CARCINOMA; PRIORITY JOURNAL; RACE DIFFERENCE;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; CARCINOMA, PANCREATIC DUCTAL; DEMOGRAPHY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENES, RAS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTATION; PANCREATIC NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0037216412     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-200301000-00006     Document Type: Article

References (29)

1. Ries LAG, Miller BA, Hankey BF, et al., eds. SEER Cancer Statistics Review: 1973-1991. Bethesda, MD: National Institutes of Health. 1994.
2. Ries LA, Wingo PA, Miller DS, et al. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer 2000;88:2398-424.
3. Silverman DT, Swanson CA, Gridley G, et al. Dietary and nutritional factors and pancreatic cancer: A case-control study based on direct interviews. J Natl Cancer Inst 1998;90:1710-9.
4. Silverman DT, Dunn JA, Hoover RN, et al. Cigarette smoking and pancreas cancer: A case-control study based on direct interviews. J Natl Cancer Inst 1994;86:1510-6.
5. Ahlgren JD. Epidemiology and risk factors in pancreatic cancer. Semin Oncol 1996;23:241-50.
6. Silverman DT, Brown LM, Hoover RN, et al. Alcohol and pancreatic cancer in blacks and whites in the United States. Cancer Res 1995;55:4899-905.
7. Bradley CJ, Given CW, Roberts C. Disparities in cancer diagnosis and survival. Cancer 2001;91:178-88.
8. Prout GR Jr, Wesley MN, Greenberg RS, et al. Bladder cancer: Race differences in extent of disease at diagnosis. Cancer 2000;89:1349-58.
9. Merrill RM, Lyon JL. Explaining the difference in prostate cancer mortality rates between white and black men in the United States. Urology 2000;55:730-5.
10. Longnecker DS, Karagas MR, Tosteson TD, et al. Racial differences in pancreatic cancer: Comparison of survival and histologic types of pancreatic carcinoma in Asians, blacks, and whites in the United States. Pancreas 2000;21:338-43.
11. Dugan MC, Dergham ST, Kucway R, et al. HER-2/neu expression in pancreatic adenocarcinoma: Relation to tumor differentiation and survival. Pancreas 1997;14:229-36.
12. Dergham ST, Dugan MC, Joshi US, et al. The clinical significance of p21(WAF1/CIP-1) and p53 expression in pancreatic adenocarcinoma. Cancer 1997;80:372-81.
13. Dergham ST, Dugan MC, Arlauskas P, et al. Relationship of family cancer history to the expression of p53. p21WAF-1, HER-2/neu, and K-ras mutation in pancreatic adenocarcinoma. Int J Pancreatol 1997;21:225-34.
14. Dergham ST, Dugan MC, Kucway R, et al. Prevalence and clinical significance of combined K-ras mutation and p53 aberration in pancreatic adenocarcinoma. Int J Pancreatol 1997;21:127-43.
15. Pernick NL, Sarkar F, Adsay NV. Fas and Fas ligand expression in pancreatic adenocarcinoma [abstract]. Pancreas 2000;21:470.
16. Feng J, Nassar H, Li Y, et al. P27 expression in pancreatic adenocarcinoma and its correlation with clinical and biologic parameters [abstract]. Mod Pathol 1999;12:162A.
17. Sarkar FH, Valdivieso M, Borders J, et al. A universal method for the mutational analysis of K-ras and p53 gene in non-small-cell lung cancer using formalin-fixed paraffin-embedded tissue. Diagn Mol Pathol 1995;4:266-73.
18. Nagata Y, Abe M, Motoshima K, et al. Frequent glycine-to-aspartic acid mutations at codon 12 of c-Ki-ras gene in human pancreatic cancer in Japanese. Jpn J Cancer Res 1990;81:135-40.
19. Motojima K, Urano T, Nagata Y, et al. Mutations in the Kirsten-ras oncogene are common but lack correlation with prognosis and tumor stage in human pancreatic carcinoma. Am J Gastroenterol 1991;86:1784-8.
20. Song MM, Nio Y, Dong M, et al. Comparison of K-ras point mutations at codon 12 and p21 expression in pancreatic cancer between Japanese and Chinese patients. J Surg Oncol 2000;75:176-85.
21. Hruban RH, van Mansfeld AD, Offerhaus GJ, et al. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol 1993;143:545-54.
22. Dong M, Nio Y, Tamura K, et al. Ki-ras point mutation and p53 expression in human pancreatic cancer: A comparative study among Chinese, Japanese, and Western patients. Cancer Epidemiol Biomarkers Prev 2000;9:279-84.
23. Smit VT, Boot AJ, Smits AM, et al. KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas. Nucleic Acids Res 1988;16:7773-82.
24. Grunewald K, Lyons J, Frohlich A, et al. High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas. Int J Cancer 1989;43:1037-41.
25. Newcomb EW, Diamond LE, Sloan SR, et al. Radiation and chemical activation of ras oncogenes in different mouse strains. Environ Health Perspect 1989;81:33-7.
26. Cella DF, Orav EJ, Kornblith AB, et al. Socioeconomic status and cancer survival. J Clin Oncol 1991;9:1500-9.
27. Niederhuber JE, Brennan MF, Menck HR. The National Cancer Data Base report on pancreatic cancer. Cancer 1995;76:1671-7.
28. Neoptolemos JP, Stocken DD, Dunn JA, et al. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized control trial. Ann Surg 2001;234:758-68.
29. Adsay NV, Pierson C, Sarkar F, et al. Colloid (mucinous noncystic) carcinoma of the pancreas. Am J Surg Pathol 2001;25:26-42.